Skip to main content

Search results

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

Scroll down for content
A diabetes patient speaks with a doctor in Central African Republic

Living with diabetes in Central African Republic

story Nov 13, 2025

News Nov 12, 2025

Staggering malnutrition rates in Sudan amid wider emergency

Mothers and their children wait to receive Plumpy'Nut, a fortified peanut-based paste used to treat moderate acute malnutrition, at a clinic in Dabaniera camp in Tawila, North Darfur.

News Nov 10, 2025

COP30 must address health needs of communities affected by the climate emergency

MSF larviciding team walks through a marsh in DR Congo.

story Nov 13, 2025

A chance at life amid genocide: A father and son’s journey from Gaza

MSF nurse Mohammad and his son Omar sit in the playground at MSF's reconstructive surgery hospital in Amman, Jordan, where Omar is being treated for an injury sustained in an Israeli airstrike in Gaza.

story Nov 06, 2025

MSF supplies arrive in Jamaica to help people affected by Hurricane Melissa

MSF staff truck water to areas affected by Hurricane Melissa in Jamaica

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

19 results

Story | Nov 13, 2025

Living with diabetes in Central African Republic

Patient empowerment is at the core of MSF’s diabetes project in Carnot, helping patients self-manage their health and thrive.

Read more
A diabetes patient speaks with a doctor in Central African Republic

Story | Sep 19, 2025

How conflict, displacement, and corporate decisions impact diabetes care

The stories of three people living with diabetes shed light on the importance of sustained access to lifesaving care.

Read more
Tawfik has to take insulin every day in addition to around six other pills to help control his diabetes and hypertension.

News | Sep 05, 2025

MSF welcomes addition of new diabetes medicines to WHO Essential Medicines List

Key diabetes treatments must be available and affordable for people who need them, no matter where they live.

Read more
MSF midwife Esther Karume screens a woman for diabetes in Kiribati, an island nation with high rates of the disease.

Story | Jul 03, 2025

Health workers on island nation of Kiribati face extraordinary challenges, including climate change

Community-based care is essential to addressing high rates of non-communicable diseases and malnutrition.

Read more
MSF bases operations on the outer island of Abaiang from an open air hut.

Story | Nov 14, 2024

Migration with diabetes: Stories from people on the move

In challenging humanitarian situations, insulin pens can be a lifeline for migrants managing this challenging disease.

Read more
Ghassan, a diabetes patient, holds an insulin pen in Greece.

News | Nov 12, 2024

Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 each

Some 80 percent of people with diabetes live in countries where insulin pens are priced out of reach.

Read more
A pile of insulin pens and caps used to treat diabetes.

News | Sep 23, 2024

Diabetes medication must be made affordable and accessible

Eli Lilly, Novo Nordisk, and Sanofi must drop their prices and stop blocking generic manufacturers from entering the market.

Read more
A close-up shot of an MSF doctor pricking a patient's finger to measure the glucose levels in their blood.

News | May 08, 2024

Diabetes: Only half of people who need insulin in the world have access to it

The US must do more to ensure that insulin pens and newer diabetes medicines are more affordable worldwide.

Read more
A diabetic refugee from Somalia sits in Dagahaley camp, Kenya, holding his insulin.

Story | Apr 17, 2024

Tackling chronic kidney disease in Guatemala

Even with limited resources, quality care and follow-up for chronic kidney disease is possible with the help of health authorities.

Read more
MSF staff meet a patient with chronic kidney disease in Guatemala

News | Mar 29, 2024

MSF study reveals global double standard in diabetes care

Insulin pens and newer diabetes drugs like Ozempic are sold at a dramatic markup in the US, while they are unavailable in low- and middle-income countries.

Read more
A woman holds her diabetes medications including insulin pens.
For Donation Inquiries 
See donor options here
 
U.S. Media Inquiries 

Reach out to the press team
 
Non-U.S. Media Inquiries 

Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.